Food and Drug Administration headquarters in White Oak, Maryland, on Aug. 29, 2020. Andrew Kelly/Reuters
The Food and Drug Administration (FDA) on Oct. 16 announced the first batch of drugs that will receive expedited reviews under the Commissioner’s National Priority Voucher (CNPV) pilot program.
“Voucher recipients will receive a decision within 1–2 months following filing of a complete application for a drug or biologic,” the FDA said, far outpacing the previous timelines.
We had a problem loading this article. Please enable javascript or use a different browser. If the issue persists, please visit our help center.
Original News Source Link – Epoch Times
Running For Office? Conservative Campaign Consulting – Election Day Strategies!